Brand Capital · The Law of the Label · One
Three Contracts People Call One Thing
Private label, white label and contract manufacturing — and why OEM is a word rather than an arrangement.
Founders describe their factory relationship with whichever of four words they heard most recently. The words are not synonyms. They describe three different allocations of ownership, and the one a founder is actually in is decided by facts, not by the heading on the agreement.
Paul Magaji · 14 min
Two founders order from the same plant in Ogun State. Both sell a hair oil. Both have a registered mark, a designed bottle and a following. Both describe what they do, when asked, as private label.
Four years later one of them moves her production to a larger factory in Lagos, takes her formulation with her, keeps her customers and improves her margin. The other tries to move and discovers that the product she has been selling for four years is a standard line the factory sells to eleven other buyers under eleven other names, that the formulation was never hers, and that if she leaves she will be launching a new product with an old name attached to it.
They were never in the same arrangement.
They were only using the same word.
The vocabulary of this trade is loose, and the looseness is not harmless. It travels into the contract, where a document headed Private Label Manufacturing Agreementmay describe, in its operative clauses, a plain purchase of the factory’s own goods. It travels into the founder’s own thinking, where the belief that one is building an asset survives for years without a single fact supporting it.
This essay separates the three arrangements, disposes of the fourth word, and gives a test that works regardless of what the paperwork is called.
Act One
What the distinction is actually about
The difference between these arrangements is not the size of the order, the language of the contract, or whether the factory is in Sango Ota or Shenzhen. It is a single question in three parts: who created the specification, who may lawfully use it, and what becomes of it when the relationship ends.
Everything else follows. If the factory created the specification and may sell it to anyone, the buyer has bought goods and applied a name to them. If the buyer created the specification and the factory may not use it elsewhere, the buyer has bought manufacturing capacity for a product that is already hers. Between those poles sits the common and genuinely difficult middle case, where the buyer brought an idea and a brief, the factory’s technical staff turned it into something manufacturable, and neither party can now say cleanly whose it is.
The commercial consequences of that question are large and delayed. They do not appear in the first year, when everyone is pleased. They appear when the founder wants to raise money against the business, sell it, add a second factory, survive a price increase, or leave. At that moment the founder is asked to prove what she owns, and the answer is determined by facts that were settled — or left unsettled — at the beginning.
Act Two
The three arrangements
Arrangement One
White label
The factory's product, your name. You own the name and nothing beneath it.
The factory has already developed a product. It manufactures that product continuously, offers it to any buyer who will take a minimum quantity, and prints whatever name the buyer supplies. The buyer chooses a name, a bottle from the factory’s catalogue and a label design. Nothing about the product itself is the buyer’s.
This is a trading position and it is a perfectly respectable one. It is fast, it requires almost no capital, and it lets a seller with distribution turn that distribution into margin immediately. Many substantial Nigerian businesses began exactly here and were right to.
What it is not is an asset position. The buyer’s competitors may be selling the identical liquid in a different bottle at a lower price, and the buyer has no ground to object, because there is nothing to object with. The only thing the buyer owns is the mark and whatever goodwill attaches to it, which in a market where the underlying product is undifferentiated is a thinner asset than it feels.
The tell
The factory showed you samples before you described what you wanted. There is a catalogue. The minimum order is low. Nobody asked you for a specification, because one already existed.
Arrangement Two
Private label
A product built to your brief, on the factory's platform. You own part of the specification. Which part is a matter of proof.
The buyer arrives with requirements — a texture, a scent, a price point, a claim she wants to be able to make, a competitor’s product she wants matched or bettered. The factory develops something to meet them. The result is not in any catalogue, and the factory did not have it before the buyer asked.
This is where most serious Nigerian consumer brands actually sit, and it is the most legally ambiguous of the three. The buyer contributed the concept, the commercial judgement and the money. The factory contributed the formulation science, the raw-material sourcing and the process. Both contributions are real. Absent a clause allocating the result, the party holding the laboratory record and the process knowledge holds the practical position, whatever the moral case.
The ambiguity is resolvable, cheaply, at the outset. It is resolved by saying in writing who owns the developed formulation, whether the factory may supply anything materially similar to another buyer, and for how long that restraint runs. A development-cost contribution from the buyer strengthens the claim considerably. Silence favours the factory, and silence is the norm.
The tell
There was a development period. There were samples that came back wrong and were revised. Somebody at the factory called it a project. And no document anywhere records who ended up owning what that project produced.
Arrangement Three
Contract manufacturing
Your product, their hands. You are buying capacity, not goods.
The buyer owns the formulation outright — she developed it, she bought it, or she commissioned its development under a contract that assigned it to her. She provides the specification to the factory, which manufactures to it under confidentiality and may not use it for anyone else. The factory is a supplier of capacity and quality assurance.
This is the only one of the three in which the product is genuinely portable. The buyer may take the specification to a second factory for capacity, to a third for a better price, or across a border. Her negotiating position with any single manufacturer is structurally strong, because she is buying something several plants can supply.
It is also the most demanding. It requires the buyer to have or acquire real technical capability, to invest in development before revenue, and often to pay more per unit than a white-label equivalent. Founders reach this arrangement deliberately or not at all.
The tell
You could describe your product to a stranger in enough detail for them to make it. The specification exists as a document you hold. A confidentiality agreement was signed before the factory saw it.
A factory that could sell your product to your competitor tomorrow is not making your product. It is making its product, in your name.
Act Three
OEM is a word, not an arrangement
Original equipment manufacturer is a term borrowed from the automotive and electronics industries, where it has a settled but counter-intuitive meaning that has never travelled well. In its home industries it is used inconsistently even by people who work there: sometimes for the firm whose brand goes on the finished machine, sometimes for the firm that supplies the components inside it. The term survives because everyone in those industries already knows which is meant from context.
Imported into Nigerian consumer trade, it has lost even that. In practice it is used to mean roughly manufactured abroad with my logo on it, which describes a shipping arrangement rather than an ownership one. A founder who says she does OEM may be in any of the three arrangements above, and usually the first.
The practical rule is simple. The word is acceptable in conversation and unacceptable in a contract. A document that turns on the meaning of OEM turns on nothing, because the term has no settled content a Nigerian court would be obliged to adopt. Where a supplier proposes it, the correct response is not to argue about the word but to replace it with the operative facts: who owns the specification, who may use it, what happens on termination.
Act Four
Three questions that place you correctly
Contracts are titled optimistically. The arrangement a founder is actually in can be established without reading one, by answering three questions honestly.
Who wrote the specification? Not who paid for the goods — who determined what the goods would be. If the answer is that the factory did, and the buyer selected from what was offered, the arrangement is white label whatever it is called. If the answer is that the buyer specified and the factory executed, it is contract manufacturing. If the answer is that both did, in a development process nobody documented, it is private label and the ownership question is live.
Could the factory lawfully supply this exact product to a competitor next week? This is the question that most reliably separates comfortable belief from actual position. Not whether the factory would — relationships and decency go a long way — but whether it could, without breaching anything. If it could, the buyer’s differentiation rests entirely on the name and the shelf.
If the relationship ended tomorrow, what could the buyer take to another factory? A name, always. A design, if it was assigned. A specification, only if she holds it and is entitled to use it. A regulatory registration, only if it stands in her name or can be transferred. The honest inventory here is short for most founders, and the shortness of it is the most useful thing this essay can offer.
Three answers place a founder on the spectrum. The placement is not a verdict on the business. It is a statement of where she currently stands, from which a decision can be made.
Act Five
The ladder, and the honest case for standing still
The three arrangements form a ladder, and the temptation of an essay like this one is to insist that everybody climb it. That would be bad advice.
Moving from white label to private label costs development money and time, and buys differentiation and a formulation claim worth arguing about. Moving from private label to contract manufacturing costs more — real technical capability, real ownership of the science, often a worse unit price — and buys portability, negotiating power and an asset that can be sold or licensed. Each step is a genuine investment with a genuine return, and each is worth making at the point where the business can carry it.
But a business trading profitably on a white-label line, with good distribution and a name customers trust, is not doing something wrong. It is running a trading business, and trading businesses are legitimate and often lucrative. The error is not staying on the first rung. The error is standing on the first rung while telling investors, buyers, heirs and oneself that one is standing on the third.
What a founder owes herself is an accurate statement of position. If she is white label, she should price the business as a trading business, invest in the two things she actually owns — the mark and the distribution — and not be surprised when a buyer values it accordingly. If she intends to climb, she should know what the next rung costs and treat it as a capital project rather than a hope.
The essays that follow assume the reader has done this placement, because almost every subsequent question changes its answer depending on the rung. Who owns the name is a different question at each level. What the contract must say is different. What happens when the product harms someone is different. And what a business owns when it owns a brand depends throughout on which rung the answer is being given from. Where a founder stands determines what she should be worried about, and most founders are worried about the wrong things because they have misplaced themselves.
The heading tells you what the agreement was called. The specification tells you what it is.
This publication is educational and analytical. It describes how legal and commercial structures work; it does not advise on any particular matter, and nothing here should be relied upon as advice on a reader’s own affairs. The author holds commercial interests in the brand-building and private-label sector examined by this series.